Cost of cancer in Europe evaluated at EUR 126 billion per year
A study by the University of Oxford published in The Lancet estimates the cost of cancer for Europe 27 countries at EUR 126 billion per year. The study is based on 2009 figures.
Healthcare expenditures represent EUR 51 billion. The rest can be attributed by productivity loss, loss of working days or evaluation of time dedicated by relatives.
Out of the EUR 51 billion, hospital expenditures come first (EUR 28.4 billion) followed by the cost of drugs (EUR 13.6 billion).
Cancer healthcare expenditures represent four percent of Europe’s total healthcare expenditures with an equivalent of EUR 102 spent for each European citizen.
The cost of cancer in Europe is far behind cardiovascular disease which is estimated at EUR 191 billion.